Skip to main content
. 2022 May 12;2022:8093949. doi: 10.1155/2022/8093949

Figure 1.

Figure 1

MALAT1 suppression or JQ1 treatment decreased proliferation (a), promoted apoptosis (b), suppressed migration (c), and inhibited the CSC-like properties (tumorsphere formation (d) and side population (SP) cell content (e) of laryngocarcinoma cells. ∗∗P < 0.01 compared with the control group. #P < 0.05 and ##P < 0.01 compared with the JQ1 group.